Free Trial
OTCMKTS:INBP

Integrated BioPharma (INBP) Stock Price, News & Analysis

Integrated BioPharma logo
$0.28 0.00 (0.00%)
As of 08/8/2025

About Integrated BioPharma Stock (OTCMKTS:INBP)

Key Stats

Today's Range
$0.28
$0.28
50-Day Range
$0.26
$0.36
52-Week Range
$0.16
$0.42
Volume
N/A
Average Volume
11,403 shs
Market Capitalization
$8.67 million
P/E Ratio
7.00
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive INBP Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Integrated BioPharma and its competitors with MarketBeat's FREE daily newsletter.

INBP Stock News Headlines

INBP Integrated BioPharma, Inc.
Altucher: $900 to $108,000? Trump’s “Great Gain” Is Here
James Altucher says two recent events could trigger a historic wealth shift—one driven by a radical Trump policy move, and the other tied to a proven financial pattern that previously minted over 80,000 new millionaires. He believes a small $900 investment could turn into a $108,000 windfall within 12 months—and this may be the last chance for everyday investors to catch it.
Integrated Biopharma Inc (INBP)
Integrated BioPharma, Inc. (INBP)
See More Headlines

INBP Stock Analysis - Frequently Asked Questions

Integrated BioPharma's stock was trading at $0.3297 at the beginning of the year. Since then, INBP stock has decreased by 15.1% and is now trading at $0.28.

Integrated BioPharma Inc. (OTCMKTS:INBP) posted its quarterly earnings results on Wednesday, May, 14th. The company reported $0.02 earnings per share (EPS) for the quarter. The business earned $13.95 million during the quarter. Integrated BioPharma had a trailing twelve-month return on equity of 6.36% and a net margin of 2.37%.

Shares of INBP stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Integrated BioPharma investors own include GSK (GSK), Invitae (NVTA), Exxon Mobil (XOM), Autodesk (ADSK), Adaptive Biotechnologies (ADPT), Analog Devices (ADI) and Adaptimmune Therapeutics (ADAP).

Company Calendar

Last Earnings
5/14/2025
Today
8/10/2025
Next Earnings (Estimated)
9/18/2025
Fiscal Year End
6/30/2026

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Sector
Medical
Industry
MED - DRUGS
Sub-Industry
Pharmaceutical Products
Current Symbol
OTCMKTS:INBP
CIK
1016504
Employees
150
Year Founded
1995

Profitability

EPS (Trailing Twelve Months)
$0.04
Trailing P/E Ratio
7.00
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
$110 thousand
Net Margins
2.37%
Pretax Margin
3.55%
Return on Equity
6.36%
Return on Assets
4.84%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
3.72
Quick Ratio
1.70

Sales & Book Value

Annual Sales
$50.32 million
Price / Sales
0.17
Cash Flow
$0.04 per share
Price / Cash Flow
6.32
Book Value
$0.64 per share
Price / Book
0.44

Miscellaneous

Outstanding Shares
30,980,000
Free Float
10,160,000
Market Cap
$8.67 million
Optionable
Not Optionable
Beta
0.80

Social Links

A Guide To High-Short-Interest Stocks Cover

MarketBeat's analysts have just released their top five short plays for August 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.

Get This Free Report

This page (OTCMKTS:INBP) was last updated on 8/10/2025 by MarketBeat.com Staff
From Our Partners